NCT03373825 (RAPiDS2) is a NA clinical trial of Take home rapid drug test in Accidental Overdose of Opiate, sponsored by Brown University.

Who is sponsoring NCT03373825?

NCT03373825 is sponsored by Brown University.

What drugs are being tested in NCT03373825?

Interventions in NCT03373825: Take home rapid drug test.

What condition does NCT03373825 study?

NCT03373825 studies Accidental Overdose of Opiate.

Is NCT03373825 still recruiting?

NCT03373825 is currently completed. Last updated 24 January 2018.

Last reviewed 2018-01-24 · How we verify

NCT03373825: RAPiDS2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs

Completed NA Last updated 24 January 2018

What this trial tests

NA trial testing Take home rapid drug test in Accidental Overdose of Opiate in 93 participants. Completed in 15 December 2017.

Timeline

15 May 2017

Primary endpoint
18 October 2017

15 December 2017

Quick facts

Lead sponsor	Brown University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	93
Start date	15 May 2017
Primary completion	18 October 2017
Estimated completion	15 December 2017
Sites	1 location across United States

Drugs / interventions tested

Take home rapid drug test

Conditions studied

Accidental Overdose of Opiate — all drugs for Accidental Overdose of Opiate →

Sponsor

Brown University

Who can join

Adults 18 to 35, any sex, with Accidental Overdose of Opiate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research team will enroll 100 young adults who use cocaine, heroin, inject drugs, or purchase prescription medications on the illicit market in a pilot study to be known as the Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS). Participants will be trained to use a take-home home rapid drug test to test for the presence or absence of fentanyl in their drug supply. Half of the enrolled participants will be asked to test their urine for presence or absence of fentanyl, and the other half will be asked to test their drug residue for presence or absence of fentanyl. All participants will receive up to 15 take-home rapid drug tests for fentanyl. A follow-up survey will examine and compare utilization of the tests between the two groups. The study will be guided by the information-motivation-behavioral skills (IMB) model of engagement in health behaviors. The IMB model hypothesizes that if a person possesses the information, motivation, and behavioral skills to act, there is an increased likelihood that she/he will fulfill and maintain the desired behaviors (behaviors that will reduce accidental overdose).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
Goldman JE, Waye KM, Periera KA, Krieger MS, et al · · 2019 · cited 122× · PMID 30621699 · DOI 10.1186/s12954-018-0276-0

Verify or expand the search:

Other Brown University trials

Trials by the same sponsor.

NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03373825 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brown University
Last refreshed: 24 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03373825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing